Pana Tiberiu A, Mamas Mamas A, Myint Phyo K, Dawson Dana K
School of Medicine and Dentistry, Foresterhill, Aberdeen Cardiovascular and Diabetes Centre, Institute of Medical Sciences, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen AB25 2ZS, United Kingdom.
School of Medicine and Dentistry, Foresterhill, Ageing Clinical and Experimental Research Team, School of Medicine, Medical Sciences and Nutrition, Institute of Applied Health Sciences, University of Aberdeen, Aberdeen AB25 2ZS, United Kingdom.
Eur J Prev Cardiol. 2025 Jun 3;32(8):696-707. doi: 10.1093/eurjpc/zwae333.
We investigate sex disparities in management and outcomes of myocardial infarction (MI) in contemporary practice in Scotland.
This was a longitudinal cohort study including all MI admissions aged 45-80 years across Scotland between 2010-2016 and 2:1 age, sex, and general practice-matched general population controls. Participants were followed up until the end of 2021. We analysed in-hospital outcomes (percutaneous coronary intervention, secondary prevention and mortality) using Poisson regressions, adjusting for age, comorbidities, and ST-elevation. We used Royston-Parmar models for long-term outcomes (all-cause and cardiovascular mortality, incident cardiovascular events), adjusting for age, comorbidities, and secondary prevention. Of a total 47 063 MI patients, 15 776 (33.5%) were women. Median (inter-quartile range) age was 66 (57, 73) years. Compared to men, women were older and more comorbid, but were less likely to undergo percutaneous coronary intervention [risk ratio (95% confidence interval) - 0.87 (0.86 - 0.89)] or receive secondary prevention at discharge [0.94 (0.93-0.95)]. No in-hospital mortality difference was observed between sexes [1.06 (0.99-1.13) after adjustment]. Over a median follow-up of 8.2 (6.7, 10.1) years, women had higher crude rates of adverse outcomes. After full adjustment, this translated into a lower risk for women compared to men of all-cause mortality [hazard ratio, 0.92 (0.89-0.95)], cardiovascular mortality [0.82 (0.78-0.87)], and cardiovascular events [0.92 (0.88-0.95)]. The female survival advantage seen in general population controls was attenuated in MI patients.
Women were undertreated compared to men after MI. Their survival and outcome benefits may be improved further. Poor outcomes in men despite better receipt of secondary prevention require further attention.
我们研究了苏格兰当代实践中心肌梗死(MI)管理和结局方面的性别差异。
这是一项纵向队列研究,纳入了2010年至2016年间苏格兰所有年龄在45至80岁的MI住院患者,以及年龄、性别和全科医疗相匹配的一般人群对照,比例为2:1。对参与者进行随访直至2021年底。我们使用泊松回归分析住院结局(经皮冠状动脉介入治疗、二级预防和死亡率),并对年龄、合并症和ST段抬高进行了调整。我们使用罗伊斯顿 - 帕尔马模型分析长期结局(全因死亡率和心血管死亡率、心血管事件发生率),并对年龄、合并症和二级预防进行了调整。在总共47063例MI患者中,15776例(33.5%)为女性。年龄中位数(四分位间距)为66(57,73)岁。与男性相比,女性年龄更大,合并症更多,但接受经皮冠状动脉介入治疗的可能性较小[风险比(95%置信区间) - 0.87(0.86 - 0.89)],出院时接受二级预防的可能性也较小[0.94(0.93 - 0.95)]。两性之间未观察到住院死亡率差异[调整后为1.06(0.99 - 1.13)]。在中位随访8.2(6.7,10.1)年期间,女性不良结局的粗发生率较高。在进行全面调整后,与男性相比,女性的全因死亡率[风险比,0.92(0.89 - 0.95)]、心血管死亡率[0.82(0.78 - 0.87)]和心血管事件[0.92(0.88 - 0.95)]风险较低。在一般人群对照中观察到的女性生存优势在MI患者中有所减弱。
与男性相比,MI后女性的治疗不足。她们的生存和结局获益可能会进一步改善。尽管男性接受二级预防的情况较好,但不良结局仍需进一步关注。